  
<prompt> Trends in IPTp use by pregnant women
 Percentage of women with a live birth in the 2 years before the survey who received at least 1, 2, or 3 doses of SP/Fansidar 
 [["", "IPTp1+", "IPTp2+", "IPTp3+"], ["2004-05 TDHS", 53, 22, 3], ["2007-08 THMIS", 59, 31, 7], ["2010 TDHS", 63, 27, 3], ["2011-12 THMIS", 63, 33, 4], ["2015-16 TDHS-MIS", 69, 35, 8], ["2017 TMIS", 83, 56, 26]] 
 <response> The percentage of women receiving IPTp1+ increased from 53% in the 2004-05 TDHS to 83% in the 2017 TMIS, the percentage receiving IPTp2+ increased from 22% to 56% between these surveys, and the percentage receiving IPTp3+ increased from 3% to 26% between the 2 surveys.  